SMSLIFE.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India...

Stats
Šios dienos apimtis	1 505.00
Vidutinė apimtis	5 838.00
Rinkos kapitalizacija	2.04B
EPS	INR0 ( 2024-02-10 )
Kita pelno data	( INR0 ) 2024-05-27
Last Dividend	INR1.500 ( 2023-09-22 )
Next Dividend	INR0 ( N/A )
P/E	41.66
ATR14	INR2.19 (0.33%)

Tūris Koreliacija

Ilgas: -0.06 (neutral)

Trumpas: -0.71 (moderate negative)

Signal:(47.129) Neutral

SMS Lifesciences India Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

SMS Lifesciences India Koreliacija - Valiuta/Žaliavos

0.43
( neutral )

0.60
( weak )

-0.45
( neutral )

0.55
( weak )

-0.02
( neutral )

-0.60
( weak negative )

SMS Lifesciences India Finansinės ataskaitos

Annual	2022
Pajamos:	INR3.16B
Bruto pelnas:	INR875.57M (27.75 %)
EPS:	INR37.92

FY	2022
Pajamos:	INR3.16B
Bruto pelnas:	INR875.57M (27.75 %)
EPS:	INR37.92

FY	2022
Pajamos:	INR3.47B
Bruto pelnas:	INR875.42M (25.21 %)
EPS:	INR83.61

FY	2021
Pajamos:	INR2.57B
Bruto pelnas:	INR702.13M (27.27 %)
EPS:	INR44.84

Financial Reports:

No articles found.

SMS Lifesciences India Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

SMS Lifesciences India Dividend Information - Dividend Junior

Dividend Sustainability Score: 1.887 - low (50.00%) | Divividend Growth Potential Score: 4.11 - Stable (17.89%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.500	2019-09-19
Last Dividend	INR1.500	2023-09-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR6.00	--
Avg. Dividend % Per Year	0.14%	--
Score	1.19	--
Div. Sustainability Score	1.887
Div.Growth Potential Score	4.11
Div. Directional Score	3.00	--

Next Divdend (Est)
(2024-12-09)

INR1.512 Estimate 2.94 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.19

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2019	INR1.500	0.31%
2020	INR0	0.00%
2021	INR1.500	0.24%
2022	INR1.500	0.20%
2023	INR1.500	0.24%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TASTYBITE.NS	Dividend Junior	2023-07-14	Annually	8	0.01%
NH.NS	Dividend Junior	2023-07-06	Sporadic	6	0.14%
IMPAL.NS	Dividend Junior	2023-07-20	Annually	19	1.79%
CHEVIOT.NS	Dividend Junior	2023-08-03	Annually	3	1.62%
SALASAR.NS	Dividend Junior	2023-09-15	Annually	8	1.41%
LUPIN.NS	Dividend Junior	2023-07-14	Annually	23	0.37%
GIPCL.NS	Dividend Junior	2023-09-08	Annually	21	2.50%
ASHIANA.NS	Dividend Junior	2023-09-21	Annually	14	0.37%
TIMETECHNO.NS	Dividend Junior	2023-09-18	Annually	17	0.93%
PARADEEP.NS	No Dividend Player	2023-09-18	Insufficient data to determine frequency	2	0.28%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0175	1.500	9.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0278	1.500	-0.802	-1.203	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1.171	1.000	-0.677	-0.677	[3 - 30]
operatingCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.248	1.000	9.19	9.19	[0.2 - 0.8]
operatingProfitMarginTTM	0.0382	1.000	-1.236	-1.236	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				1.887

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	41.71	1.000	5.89	0	[1 - 100]
returnOnEquityTTM	0.0278	2.50	-0.516	-1.203	[0.1 - 1.5]
freeCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.222	1.500	4.44	0	[0 - 0.4]
operatingCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.481	1.500	-0.129	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.101	1.000	9.98	0	[0.1 - 0.5]
Total Score				4.11

SMS Lifesciences India

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.